These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response. Horscroft N; Bellows D; Ansari I; Lai VC; Dempsey S; Liang D; Donis R; Zhong W; Hong Z J Virol; 2005 Mar; 79(5):2788-96. PubMed ID: 15708997 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus virology and new treatment targets. Meier V; Ramadori G Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246 [TBL] [Abstract][Full Text] [Related]
7. Application of the trak-C HCV core assay for monitoring antiviral activity in HCV replication systems. Cagnon L; Wagaman P; Bartenschlager R; Pietschmann T; Gao T; Kneteman NM; Tyrrell DL; Bahl C; Niven P; Lee S; Simmen KA J Virol Methods; 2004 Jun; 118(1):23-31. PubMed ID: 15158065 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy. Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis C: a new horizon. Chang KM Gastroenterology; 2006 Dec; 131(6):1667-8. PubMed ID: 17188957 [No Abstract] [Full Text] [Related]
10. Chemical genetics approach to hepatitis C virus replication: cyclophilin as a target for anti-hepatitis C virus strategy. Watashi K; Shimotohno K Rev Med Virol; 2007; 17(4):245-52. PubMed ID: 17299803 [TBL] [Abstract][Full Text] [Related]
11. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Watashi K; Hijikata M; Hosaka M; Yamaji M; Shimotohno K Hepatology; 2003 Nov; 38(5):1282-8. PubMed ID: 14578868 [TBL] [Abstract][Full Text] [Related]
12. [Molecular mechanisms of the hepatitis C virus, potential therapeutic targets]. Rivas-Estilla AM; Panduro A Rev Invest Clin; 2003; 55(1):51-64. PubMed ID: 12708164 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model. Kim M; Shin D; Kim SI; Park M Virus Res; 2006 Dec; 122(1-2):1-10. PubMed ID: 16979254 [TBL] [Abstract][Full Text] [Related]
14. A primer on the molecular virology of hepatitis C. Moradpour D; Blum HE Liver Int; 2004 Dec; 24(6):519-25. PubMed ID: 15566499 [TBL] [Abstract][Full Text] [Related]
15. Virology. Culture systems for hepatitis C virus in sight at last. Cohen J Science; 2005 Jun; 308(5728):1539-41. PubMed ID: 15947152 [No Abstract] [Full Text] [Related]
16. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line. Zhu H; Zhao H; Collins CD; Eckenrode SE; Run Q; McIndoe RA; Crawford JM; Nelson DR; She JX; Liu C Hepatology; 2003 May; 37(5):1180-8. PubMed ID: 12717400 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methyl purine nucleosides as inhibitors of hepatitis C virus RNA replication. Clark JL; Mason JC; Hollecker L; Stuyver LJ; Tharnish PM; McBrayer TR; Otto MJ; Furman PA; Schinazi RF; Watanabe KA Bioorg Med Chem Lett; 2006 Mar; 16(6):1712-5. PubMed ID: 16368235 [TBL] [Abstract][Full Text] [Related]
18. A cyclic peptide mimic of an RNA recognition motif of human La protein is a potent inhibitor of hepatitis C virus. Manna AK; Kumar A; Ray U; Das S; Basu G; Roy S Antiviral Res; 2013 Mar; 97(3):223-6. PubMed ID: 23291201 [TBL] [Abstract][Full Text] [Related]
19. Virology of hepatitis B and C viruses and antiviral targets. Pawlotsky JM J Hepatol; 2006; 44(1 Suppl):S10-3. PubMed ID: 16338022 [TBL] [Abstract][Full Text] [Related]
20. [Hepatitis C virus infection]. Nakagawa M; Enomoto N; Sakamoto N Nihon Rinsho; 2003 Mar; 61 Suppl 3():627-33. PubMed ID: 12718039 [No Abstract] [Full Text] [Related] [Next] [New Search]